Evidence map›Paper›PMID 30717817›Full record

ArticleJournal for immunotherapy of cancer2019

TNF-α enhances Th9 cell differentiation and antitumor immunity via TNFR2-dependent pathways.

Yuxue Jiang, Jintong Chen, Enguang Bi, Yinghua Zhao, Tianxue Qin, Yiming Wang, Alison Wang, Sujun Gao, Qing Yi, Siqing Wang

Open access · goldAbstract read
In one paragraph

Article in Journal for immunotherapy of cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
3.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Evaluating the Chemical Composition and Antitumor Activity ofInternational journal of molecular sciences · 2025
    Article
  5. Article
  6. Article
  7. Differentiation and regulation of CD4Cellular and molecular life sciences : CMLS · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. The Dichotomy of Interleukin-9 Function in the Tumor Microenvironment.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2023
    Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Yuxue JiangDepartment of Cancer Immunology, The First Hospital of Jilin University, 519 Dongminzhu St, ChangChun, Jilin, China.
Jintong ChenDepartment of Cancer Immunology, The First Hospital of Jilin University, 519 Dongminzhu St, ChangChun, Jilin, China.
Enguang BiDepartment of Cancer Biology, Cleveland Clinic, Lerner Research Institute, Cleveland, OH, 44195, USA.
Yinghua ZhaoDepartment of Cancer Immunology, The First Hospital of Jilin University, 519 Dongminzhu St, ChangChun, Jilin, China.
Tianxue QinDepartment of Hematology, The First Hospital of Jilin University, Changchun, 130061, China.
Yiming WangDepartment of Orthopedics, China-Japan Union Hospital of Jilin University, Changchun, China.
Alison WangDepartment of Cancer Immunology, The First Hospital of Jilin University, 519 Dongminzhu St, ChangChun, Jilin, China.
Sujun GaoDepartment of Hematology, The First Hospital of Jilin University, Changchun, 130061, China.
Qing YiDepartment of Cancer Immunology, The First Hospital of Jilin University, 519 Dongminzhu St, ChangChun, Jilin, China.
Siqing WangDepartment of Cancer Immunology, The First Hospital of Jilin University, 519 Dongminzhu St, ChangChun, Jilin, China. siw1970@yahoo.com.ORCID 0000-0001-7311-6790
Jilin University · CNCleveland Clinic · USHouston Methodist · USUnion Hospital · CN

Funding

Targeting Plasmacytoid Dendritic Cells to Treat Human MyelomaR01CA163881 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI YI, QING · 2012 to 2016
$2.0M
A novel T-cell subset able to kill relapsed cancersR01CA200539 · NCI · METHODIST HOSPITAL RESEARCH INSTITUTE · PI YI, QING · 2016 to 2020
$1.8M
NCI NIH HHS R01 CA163881NCI NIH HHS R01 CA200539
6 · The paper itself

Abstract

Tumor specific Th9 cells are potential effector cells for adoptive therapy of human cancers. TNF family members OX40L, TL1A and GITRL have been shown to promote the induction of Th9 cells and antitumor immunity. However, the role of TNF-α, the prototype of the TNF superfamily cytokines, in Th9 cell differentiation and their antitumor efficacy is not defined. Here, we showed that TNF-α potently promoted naïve CD4

Indexed as

Cell DifferentiationAnimalsCD4-Positive T-LymphocytesCell Line, TumorImmunityMice, KnockoutNeoplasmsNF-kappa BReceptors, Tumor Necrosis Factor, Type IReceptors, Tumor Necrosis Factor, Type IITumor Necrosis Factor-alphaNF-kappa BReceptors, Tumor Necrosis Factor, Type IReceptors, Tumor Necrosis Factor, Type IITnfrsf1a protein, mouseTnfrsf1b protein, mouseTumor Necrosis Factor-alphaSTAT5Th9TNFR2TNF-α

Identifiers

PMID30717817
PMCPMC6360681
OpenAlexW2917794596

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.